Eli Lilly and Company
SELECTIVE ESTROGEN RECEPTOR DEGRADERS
Last updated:
Abstract:
Novel selective estrogen receptor degraders (SERDs) according to the formula: pharmaceutically acceptable salts, pharmaceutical compositions, uses, and methods of use thereof are provided. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
11 Jul 2019
Issue date:
26 Aug 2021